期刊文献+

氧气雾化吸入小牛血清去蛋白提取物治疗化疗相关口腔黏膜炎的疗效观察 被引量:4

Clinical efficacy of oxygen aerosol inhalation deproteinized hemoderivative of calf blood in chemotherapy-induced oral mucositis
下载PDF
导出
摘要 目的 探讨氧气雾化吸入小牛血清去蛋白提取物治疗化疗所致口腔黏膜炎的临床价值.方法 将40例接受化疗后出现口腔黏膜炎的患者随机分为观察组和对照组各20例,观察组采用3%碳酸氢钠溶液漱口基础上加用氧气雾化吸入小牛血清去蛋白提取物治疗,对照组使用3%碳酸氢钠溶液漱口.连续治疗5天,观察两组口腔溃疡治疗效果差异.结果 观察组总有效率为95%,对照组为70%,两组总有效率比较差异有统计学意义(P<0.05);观察组的口腔粘膜炎愈合需要时间较对照组缩短.结论 氧气雾化吸入小牛血清去蛋白提取物有利于肿瘤患者化疗相关性口腔黏膜炎恢复,安全性好,有临床应用价值. Objective To investigate the clinical efficacy of oxygen aerosol inhalation deproteinized hemoderivative of calf blood in the treatment of chemotherapy-induced oral mucositis.Methods 40 cases of chemothcrapy-induced oral mucositis were randomly divided into observation group and control group,20 cases in each group.Both groups were given 3% sodium bicarbonate solution gargle,observation group was given oxygen aerosol inhalation deproteinized hemoderivative of calf blood on the basis.The curative effect was observed after 5 days' treatment.Results The total effective rate of observation group was 95%,that of control group was 70%,with statistically significant difference between two groups (P〈0.05).The healing time of oral mucositis of observation group was shorter than that of control group (P〈0.05).Conclusion The method of oxygen aerosol inhalation deproteinized hemoderivative of calf blood has a significant therapeutic effect on chemotherapy-induced oral mucositis in cancer patients,and it is safe,worthy of clinical application.
出处 《国际医药卫生导报》 2015年第14期2035-2038,共4页 International Medicine and Health Guidance News
关键词 化疗相关口腔黏膜炎 小牛血清去蛋白提取物 氧气雾化吸入 Chemotherapy-induced oral mucositis Deproteinized hemoderivative of calf blood Oxygen aerosol inhalation
  • 相关文献

参考文献13

  • 1Li Y, Ping X, Yu B, et al. Clinical trial: prophylactic intravenous alanyl-glutamine reduces the severity of gastrointestinal toxicity induced by chemotherapy--a randomized crossover study[J].Aliment PharmacolTher, 2009, 30(5): 452-458.
  • 2A1-Dasooqi N, Sonis ST, Bowen JM, et al. Emerging evidence on the pathobiology of mucositis[J].Support Care Cancer, 2013, 21(11): 3233-3241.
  • 3Villa A, Sonis ST. Mucositis: pathobiology and management[J].Curr OpinOncol, 2015, 27(3): 159-164.
  • 4A1-Dasooqi N, Sonis ST, Bowen JM, et al. Emerging evidence on the pathobiology of mucositis[J].Support Care Cancer, 2013, 21(7): 2075-2083.
  • 5Jones JA, Avritscher EB, Cooksley CD, et al. Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or eolorectal eancer[J].Support Care Cancer, 2006, 14(6): 505-515.
  • 6Vagllano L, Feraut C, Gobetto G, et al. Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT--results of a multicantre study[J].Bone Marrow Transplant, 2011, 46(5) : 727- 732.
  • 7Peterson DE, Bensadoun ILl, Roila F, et al. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines[J].Ann Oncol, 2011, 22 Suppl 6: vi78-84.
  • 8Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment[J].Semin Radiat Oncol, 2003, 13(3): 176-181.
  • 9Yuan A, Sonis S. Emerging therapies for the prevention and treatment of oral mucositis[J].Expert Opin Emerg Drugs, 2014, 19(3): 343- 351.
  • 10Rodr i guez-Caballero A, Torres-Lagares D, Robles-Gare f a M, et al. Cancer treatment-induced oral mucositis: a critical review[J].Int J Oral MaxillofacSurg, 2012, 41(2): 225-238.

二级参考文献24

  • 1马志忠,汤洪川,贾建军,刘泽亭,尹龄,王国平,朱克,张志萍,张信红,李晖.爱维治治疗老年人脑血管性痴呆[J].中国新药杂志,1994,3(4):35-37. 被引量:4
  • 2张雪花,王秀芬,邓牡红.白介素-11治疗化疗所致口腔溃疡的疗效观察[J].现代护理,2005,11(22):1872-1873. 被引量:19
  • 3万江波.局部使用粒细胞-巨噬细胞集落刺激因子(GM-CSF)治疗重度粘膜炎[J].药品评价,2007,4(1):49-51. 被引量:9
  • 4王治乔 袁伯俊.新药临床前安全性评价与实践 [M].北京:军事医学科学出版社,1997.78-110.
  • 5张天泽 徐光炜.肿瘤学[M].天津:天津科学技术出版社,1996.1209.
  • 6Obermaier Kusser B, M hlbacher C, Mushack J, et al Further evidence for a two- step model of glucose- tr_ ansport regulation[J]. Biochem J, 1989, 261: 699
  • 7Siegfried Hoyer, Karen Betz Elimination of the delayed postischemic energy deficit in cerebral cortex and hipp_ ocampus of aged rats with a dried, deproteinized blood extract( Actovegin) [J]. Arch Gerontol Geriatr, 1989, 9: 181
  • 8Groot H, Brecht M, Machicao F Evidence for a factor protective against hypoxic liver parenchyal cell injury in a protein- free blood extract[J]. APRIL, 1990, 68( 1) : 125
  • 9水野美邦.神经内科手册 [M]. 第 2版.日本 : 医学书院出版社 , 1993: 121
  • 10Kanowdki S, Kinzler E, Lehmann E, et al Confirmed cli_ nical efficacy of actovegin in elderly patient with organic brain syndrome[J]. Pharmacopsychiat, 1995, 28: 125

共引文献20

同被引文献32

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部